changing hearts, minds, and the addiction treatment industry
Our Boulder Vision
Our Recovery Community
Policy & Advocacy
Research & Education
Articles tagged:
treatment
Policy & Advocacy
All eyes on Oregon: the first US state to decriminalize drugs.
Recently, journalists have targeted Portland, OR as the exemplar for an emergent debate: as the addiction crisis rages on, are policies that decriminalize low-level drug crimes helping or hurting?
Stephanie Strong
CEO & Founder
Our Boulder Vision
Telehealth Can Be A Safe Space For LGBTQIA+ SUD Patients
The disparities faced by the LGBTQ+ community in addiction treatment demand our attention. Understanding the specific challenges and consequences is crucial for promoting inclusivity and improving outcomes. It is our collective responsibility in the medical field to address these disparities through increased support, research, and advocacy.
Alann Weissman-Ward, MD
Clinician
Our Boulder Vision
Giving Ohio OUD Patients Their Best Chance at Recovery:
I’ve been a nurse in Ohio for three decades and, for the past ten years, I’ve been focused on Opioid Use Disorder patients. I have never seen a more effective model than the collaborative, whole-patient approach at Boulder Care.
Tracy Szirony
Family Nurse Practitioner
Policy & Advocacy
A plea from the frontlines:
Telehealth treatment for opioid addiction is working. Pandemic flexibilities helped Americans access life-saving medications like buprenorphine without increasing misuse. So why are we going backward? The DEA’s newly proposed “guardrails” are more aptly “roadblocks” for addiction patients and providers alike.
Susanne Johnson MSN, FNP-BC
Nurse Practitioner
Policy & Advocacy
What the DEA's Proposed Changes to Telemedicine Really Mean
The DEA announced a proposal for new rules for prescribing controlled substances - including buprenorphine - that could impact telehealth patients and add a single in-person requirement. Boulder is prepared to help patients navigate this change and fight back to make treatment easy and accessible.
Stephanie Strong
CEO & Founder
Policy & Advocacy
Stacking Stigmas:
When the stigma of abortion is added to other forms of stigma, dangerous forces multiply. From her work delivering both reproductive and SUD care to patients in need, Dr. Amy Potter shares her firsthand perspective about the impact of the SCOTUS ruling.
Amy Potter, MD
Boulder Physician
Policy & Advocacy
My Birthday Trip
Dave Lerman, Boulder's CTO, details how a personal experience helped him see a need for more support and funding for studies into the potential of psychedelics.
David Lerman
Chief Technology Officer
Policy & Advocacy
The Real Cost of Treating Disease like a Crime
Boulder Care’s Medical Director, Alyson Smith, and Community Justice expert, Jeremy Hubbard, explain why incarceration creates such dangerous situations for SUD patients -- and what can be done about it.
Alyson Smith, MD
Former Medical Director
Policy & Advocacy
The Ways We Regulate Stigma into Law
Ben MacLean, Boulder's General Counsel, explains how laws and regulations can fight against patients with SUDs and stand in the way of better treatment options.
Ben Maclean
General Counsel
Our Boulder Vision
Hollywood's Addiction to Treatment Tropes
Boulder's in-house writer, Michael, who also works in TV and film, explains how Hollywood's obsession with sad stories has created a distorted view of patients with substance use disorder.
Michael Walker
Creative Director
Policy & Advocacy
How Criminal Justice (Mis)handles Addiction
Jeremy Hubbard discusses what he learned in his 16 year career as a parole officer about what the criminal justice system gets wrong around substance use disorder, treatment, and helping inmates with addictions.
Jeremy Hubbard
Owner, Liminal Justice Consulting, LLC